MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1
Crossref DOI link: https://doi.org/10.1038/cgt.2017.6
Published Online: 2017-03-10
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Y
Niu, Z
Lin, X
Tian, Y
Text and Data Mining valid from 2017-03-10
Version of Record valid from 2017-03-10
Article History
Received: 17 December 2016
Revised: 16 January 2017
Accepted: 21 January 2017
First Online: 10 March 2017
Competing interests
: The authors declare no conflict of interest.